BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 18309878)

  • 1. [Trends in osteoporosis].
    Uebelhart B; Rizzoli R
    Rev Med Suisse; 2008 Jan; 4(140):144-6, 148-9. PubMed ID: 18309878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of pharmacological agents in managing osteoporosis in the old old: review of the evidence.
    Inderjeeth CA; Foo AC; Lai MM; Glendenning P
    Bone; 2009 May; 44(5):744-51. PubMed ID: 19130909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Osteoporosis treatment].
    Uebelhart B; Rizzoli R
    Rev Med Suisse; 2006 Jan; 2(47):47-51. PubMed ID: 16465945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Present development of new drugs for osteoporosis].
    Wada S
    Clin Calcium; 2006 Jan; 16(1):176-81. PubMed ID: 16397369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Secondary osteoporosis UPDATE. Drugs under development for metabolic bone disease].
    Endo I; Matsumoto T
    Clin Calcium; 2010 May; 20(5):700-8. PubMed ID: 20445281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: Results of a five-year, randomized, placebo-controlled trial.
    Reginster JY; Felsenberg D; Boonen S; Diez-Perez A; Rizzoli R; Brandi ML; Spector TD; Brixen K; Goemaere S; Cormier C; Balogh A; Delmas PD; Meunier PJ
    Arthritis Rheum; 2008 Jun; 58(6):1687-95. PubMed ID: 18512789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Raloxifene in clinical practice. Results of the non-interventional study CORAL (COmpliance with RALoxifene)].
    Rosa J; Vanuga P; Payer J; Svobodník A
    Vnitr Lek; 2008 Mar; 54(3):217-9, 221-4. PubMed ID: 18522288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and therapeutic aspects of osteoporosis.
    Compston J
    Eur J Radiol; 2009 Sep; 71(3):388-91. PubMed ID: 19660883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current topics in drug therapy aiming at bone resorption].
    Yasui T; Tanaka S
    Clin Calcium; 2006 Sep; 16(9):1475-79. PubMed ID: 16951471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Assessment of bone quality. Drug developments for restoring bone mass and quality in the treatment of osteoporosis].
    Nakamura T
    Clin Calcium; 2008 Mar; 18(3):374-80. PubMed ID: 18310826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-resorptive therapies for osteoporosis.
    Reid IR
    Semin Cell Dev Biol; 2008 Oct; 19(5):473-8. PubMed ID: 18760372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Osteoporosis treatment].
    Uebelhart B; Rizzoli R
    Rev Med Suisse; 2007 Jan; 3(94):150-3. PubMed ID: 17354541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of SERMs on bone health. Effects of raloxifene and bisphosphonate on bone quality in osteoporosis: collagen cross-links, mineralization, and bone strength].
    Saito M
    Clin Calcium; 2010 Mar; 20(3):345-54. PubMed ID: 20190364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention and treatment of senile osteoporosis and hip fractures.
    Duque G; Demontiero O; Troen BR
    Minerva Med; 2009 Feb; 100(1):79-94. PubMed ID: 19277006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic considerations on secondary osteoporosis caused by diabetes mellitus].
    Azuma K
    Clin Calcium; 2009 Sep; 19(9):1345-52. PubMed ID: 19721208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Future therapeutic targets in osteoporosis.
    Deal C
    Curr Opin Rheumatol; 2009 Jul; 21(4):380-5. PubMed ID: 19461517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Established and forthcoming drugs for the treatment of osteoporosis.
    Lems WF; Geusens P
    Curr Opin Rheumatol; 2014 May; 26(3):245-51. PubMed ID: 24625372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Raloxifene use in clinical practice: efficacy and safety.
    Goldstein SR; Duvernoy CS; Calaf J; Adachi JD; Mershon JL; Dowsett SA; Agnusdei D; Stuenkel CA
    Menopause; 2009; 16(2):413-21. PubMed ID: 19092711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of estrogen and selective estrogen receptor modulators in anti-aging].
    Ohta H
    Clin Calcium; 2008 Jul; 18(7):986-94. PubMed ID: 18591752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strontium ranelate: the first agent of a new therapeutic class in osteoporosis.
    Neuprez A; Hiligsmann M; Scholtissen S; Bruyere O; Reginster JY
    Adv Ther; 2008 Dec; 25(12):1235-56. PubMed ID: 19066755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.